SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'X2N'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2WX2_A_TPFA1460_1 (LANOSTEROL14-ALPHA-DEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 7 | PHE A 126TYR A 132THR A 311LEU A 376 | X2N A 590 (-4.8A)HEM A 580 (-4.1A)HEM A 580 (-3.6A)X2N A 590 (-4.3A) | 0.86A | 2wx2A-5fsaA:37.8 | 2wx2A-5fsaA:32.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2WX2_B_TPFB1460_1 (LANOSTEROL14-ALPHA-DEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 8 | TYR A 118PHE A 126TYR A 132THR A 311 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)HEM A 580 (-4.1A)HEM A 580 (-3.6A) | 0.50A | 2wx2B-5fsaA:36.3 | 2wx2B-5fsaA:32.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X2N_D_X2ND1479_1 (LANOSTEROL14-ALPHA-DEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 12 | TYR A 118PHE A 233TYR A 132LEU A 376MET A 508 | X2N A 590 ( 4.0A)X2N A 590 (-4.3A)HEM A 580 (-4.1A)X2N A 590 (-4.3A)X2N A 590 (-4.8A) | 1.16A | 2x2nD-5fsaA:39.6 | 2x2nD-5fsaA:31.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X2N_D_X2ND1479_1 (LANOSTEROL14-ALPHA-DEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 12 | TYR A 118PHE A 233TYR A 132THR A 311LEU A 376 | X2N A 590 ( 4.0A)X2N A 590 (-4.3A)HEM A 580 (-4.1A)HEM A 580 (-3.6A)X2N A 590 (-4.3A) | 0.82A | 2x2nD-5fsaA:39.6 | 2x2nD-5fsaA:31.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JUS_A_ECLA600_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 8 | TYR A 118THR A 122TYR A 132GLY A 303 | X2N A 590 ( 4.0A)NoneHEM A 580 (-4.1A)X2N A 590 ( 4.8A) | 0.59A | 3jusA-5fsaA:46.1 | 3jusA-5fsaA:39.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JUS_A_ECLA600_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 8 | TYR A 118TYR A 132GLY A 303THR A 311 | X2N A 590 ( 4.0A)HEM A 580 (-4.1A)X2N A 590 ( 4.8A)HEM A 580 (-3.6A) | 0.55A | 3jusA-5fsaA:46.1 | 3jusA-5fsaA:39.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JUS_A_ECNA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 8 | TYR A 118THR A 122TYR A 132GLY A 303 | X2N A 590 ( 4.0A)NoneHEM A 580 (-4.1A)X2N A 590 ( 4.8A) | 0.59A | 3jusA-5fsaA:46.1 | 3jusA-5fsaA:39.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JUS_A_ECNA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 8 | TYR A 118TYR A 132GLY A 303THR A 311 | X2N A 590 ( 4.0A)HEM A 580 (-4.1A)X2N A 590 ( 4.8A)HEM A 580 (-3.6A) | 0.55A | 3jusA-5fsaA:46.1 | 3jusA-5fsaA:39.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JUS_B_ECNB602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 9 | TYR A 118THR A 122TYR A 132GLY A 303THR A 311 | X2N A 590 ( 4.0A)NoneHEM A 580 (-4.1A)X2N A 590 ( 4.8A)HEM A 580 (-3.6A) | 0.63A | 3jusB-5fsaA:46.0 | 3jusB-5fsaA:39.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KHM_A_TPFA501_1 (STEROL 14ALPHA-DEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 8 | PHE A 126TYR A 132THR A 311LEU A 376 | X2N A 590 (-4.8A)HEM A 580 (-4.1A)HEM A 580 (-3.6A)X2N A 590 (-4.3A) | 0.88A | 3khmA-5fsaA:35.7 | 3khmA-5fsaA:32.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3L4D_C_TPFC490_1 (STEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 9 | TYR A 118TYR A 132THR A 311LEU A 376MET A 508 | X2N A 590 ( 4.0A)HEM A 580 (-4.1A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 (-4.8A) | 0.78A | 3l4dC-5fsaA:39.0 | 3l4dC-5fsaA:30.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LD6_A_KKKA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 6 / 12 | TYR A 118PHE A 126TYR A 132PHE A 228GLY A 303THR A 311 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)HEM A 580 (-4.1A)X2N A 590 (-4.9A)X2N A 590 ( 4.8A)HEM A 580 (-3.6A) | 0.94A | 3ld6A-5fsaA:46.5 | 3ld6A-5fsaA:39.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LD6_B_KKKB602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 6 / 12 | TYR A 118PHE A 126TYR A 132PHE A 228GLY A 303THR A 311 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)HEM A 580 (-4.1A)X2N A 590 (-4.9A)X2N A 590 ( 4.8A)HEM A 580 (-3.6A) | 0.97A | 3ld6B-5fsaA:46.3 | 3ld6B-5fsaA:39.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3R6W_A_NFZA214_1 (FMN-DEPENDENTNADH-AZOREDUCTASE 1) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 10 | PHE A 380VAL A 94PHE A 85PHE A 71GLY A 65 | X2N A 590 ( 4.8A)NoneNoneNoneX2N A 590 ( 4.0A) | 1.38A | 3r6wA-5fsaA:undetectable3r6wB-5fsaA:undetectable | 3r6wA-5fsaA:18.763r6wB-5fsaA:18.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WMZ_A_TPFA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 9 / 9 | TYR A 118PHE A 126ILE A 131TYR A 132PHE A 228GLY A 307THR A 311LEU A 376MET A 508 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)X2N A 590 (-4.2A)HEM A 580 (-4.1A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 (-4.8A) | 0.68A | 4wmzA-5fsaA:34.5 | 4wmzA-5fsaA:59.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZDY_A_1YNA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 11 / 12 | GLY A 65TYR A 118PHE A 126ILE A 131PHE A 228GLY A 307THR A 311LEU A 376HIS A 377PHE A 380MET A 508 | X2N A 590 ( 4.0A)X2N A 590 ( 4.0A)X2N A 590 (-4.8A)X2N A 590 (-4.2A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 (-4.3A)X2N A 590 ( 4.8A)X2N A 590 (-4.8A) | 0.57A | 4zdyA-5fsaA:56.9 | 4zdyA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZDY_A_1YNA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 12 | GLY A 308THR A 311LEU A 376HIS A 377MET A 508 | HEM A 580 (-3.6A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 (-4.3A)X2N A 590 (-4.8A) | 1.00A | 4zdyA-5fsaA:56.9 | 4zdyA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZDY_A_1YNA602_2 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 3 / 3 | ALA A 61TYR A 64PRO A 230 | X2N A 590 (-3.5A)NoneX2N A 590 (-4.2A) | 0.27A | 4zdyA-5fsaA:56.9 | 4zdyA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZDZ_A_TPFA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 7 / 7 | PHE A 126ILE A 131PHE A 228GLY A 307THR A 311LEU A 376MET A 508 | X2N A 590 (-4.8A)X2N A 590 (-4.2A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 (-4.8A) | 0.71A | 4zdzA-5fsaA:56.6 | 4zdzA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZE0_A_VORA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 8 / 9 | TYR A 118THR A 122PHE A 126ILE A 131PHE A 228GLY A 307THR A 311LEU A 376 | X2N A 590 ( 4.0A)NoneX2N A 590 (-4.8A)X2N A 590 (-4.2A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 (-4.3A) | 0.61A | 4ze0A-5fsaA:57.2 | 4ze0A-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZE1_A_X2NA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 10 / 12 | TYR A 64GLY A 65LEU A 121PHE A 126PHE A 228GLY A 307LEU A 376HIS A 377PHE A 380MET A 508 | NoneX2N A 590 ( 4.0A)X2N A 590 (-4.6A)X2N A 590 (-4.8A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)X2N A 590 (-4.3A)X2N A 590 (-4.3A)X2N A 590 ( 4.8A)X2N A 590 (-4.8A) | 0.54A | 4ze1A-5fsaA:56.9 | 4ze1A-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZE1_A_X2NA602_2 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 5 | TYR A 118ILE A 131PRO A 230THR A 311 | X2N A 590 ( 4.0A)X2N A 590 (-4.2A)X2N A 590 (-4.2A)HEM A 580 (-3.6A) | 0.30A | 4ze1A-5fsaA:56.9 | 4ze1A-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZE2_A_1YNA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 11 / 12 | GLY A 65TYR A 118LEU A 121PHE A 126ILE A 131PHE A 228GLY A 307THR A 311LEU A 376HIS A 377MET A 508 | X2N A 590 ( 4.0A)X2N A 590 ( 4.0A)X2N A 590 (-4.6A)X2N A 590 (-4.8A)X2N A 590 (-4.2A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 (-4.3A)X2N A 590 (-4.8A) | 0.54A | 4ze2A-5fsaA:57.2 | 4ze2A-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZE2_A_1YNA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 12 | GLY A 308THR A 311LEU A 376HIS A 377MET A 508 | HEM A 580 (-3.6A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 (-4.3A)X2N A 590 (-4.8A) | 1.07A | 4ze2A-5fsaA:57.2 | 4ze2A-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZE2_A_1YNA602_2 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 5 | ALA A 61TYR A 64PRO A 230PHE A 380 | X2N A 590 (-3.5A)NoneX2N A 590 (-4.2A)X2N A 590 ( 4.8A) | 0.41A | 4ze2A-5fsaA:57.2 | 4ze2A-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZE3_A_TPFA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 7 / 7 | TYR A 118PHE A 126ILE A 131PHE A 228GLY A 307THR A 311LEU A 376 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)X2N A 590 (-4.2A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 (-4.3A) | 0.51A | 4ze3A-5fsaA:57.7 | 4ze3A-5fsaA:59.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZVM_B_DM2B303_1 (RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE[QUINONE]) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 11 | VAL A 478PHE A 463GLY A 308GLY A 307ILE A 304 | NoneHEM A 580 ( 4.5A)HEM A 580 (-3.6A)X2N A 590 (-3.5A)HEM A 580 ( 4.6A) | 1.19A | 4zvmA-5fsaA:undetectable4zvmB-5fsaA:undetectable | 4zvmA-5fsaA:19.314zvmB-5fsaA:19.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEI_A_SHHA2004_1 (HDAC6 PROTEIN) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 12 | HIS A 310GLY A 307PHE A 228LEU A 224TYR A 221 | NoneX2N A 590 (-3.5A)X2N A 590 (-4.9A)NoneNone | 1.24A | 5eeiA-5fsaA:undetectable | 5eeiA-5fsaA:22.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEI_B_SHHB801_1 (HDAC6 PROTEIN) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 12 | HIS A 310GLY A 307PHE A 228LEU A 224TYR A 221 | NoneX2N A 590 (-3.5A)X2N A 590 (-4.9A)NoneNone | 1.24A | 5eeiB-5fsaA:undetectable | 5eeiB-5fsaA:22.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EQB_A_1YNA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 12 | GLY A 65GLY A 308LEU A 376HIS A 377MET A 508 | X2N A 590 ( 4.0A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 (-4.3A)X2N A 590 (-4.8A) | 1.02A | 5eqbA-5fsaA:57.0 | 5eqbA-5fsaA:59.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EQB_A_1YNA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 11 / 12 | GLY A 65PHE A 126ILE A 131TYR A 132PHE A 228GLY A 303GLY A 307LEU A 376HIS A 377PHE A 380MET A 508 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)X2N A 590 (-4.2A)HEM A 580 (-4.1A)X2N A 590 (-4.9A)X2N A 590 ( 4.8A)X2N A 590 (-3.5A)X2N A 590 (-4.3A)X2N A 590 (-4.3A)X2N A 590 ( 4.8A)X2N A 590 (-4.8A) | 0.59A | 5eqbA-5fsaA:57.0 | 5eqbA-5fsaA:59.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EQB_A_1YNA602_2 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 4 | TYR A 64TYR A 118PRO A 230THR A 311 | NoneX2N A 590 ( 4.0A)X2N A 590 (-4.2A)HEM A 580 (-3.6A) | 0.42A | 5eqbA-5fsaA:57.0 | 5eqbA-5fsaA:59.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ESG_A_1YNA701_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 12 | GLY A 308THR A 311LEU A 376HIS A 377MET A 508 | HEM A 580 (-3.6A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 (-4.3A)X2N A 590 (-4.8A) | 1.10A | 5esgA-5fsaA:57.3 | 5esgA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ESG_A_1YNA701_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 11 / 12 | TYR A 64PHE A 126ILE A 131TYR A 132PHE A 228VAL A 234GLY A 307THR A 311LEU A 376HIS A 377MET A 508 | NoneX2N A 590 (-4.8A)X2N A 590 (-4.2A)HEM A 580 (-4.1A)X2N A 590 (-4.9A)NoneX2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 (-4.3A)X2N A 590 (-4.8A) | 0.56A | 5esgA-5fsaA:57.3 | 5esgA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ESG_A_1YNA701_2 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 4 | LEU A 88TYR A 118PRO A 230ILE A 231 | NoneX2N A 590 ( 4.0A)X2N A 590 (-4.2A)None | 0.35A | 5esgA-5fsaA:57.3 | 5esgA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ESH_A_1YNA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 8 / 12 | ALA A 61LEU A 87PHE A 126ILE A 131TYR A 132PHE A 228GLY A 307MET A 508 | X2N A 590 (-3.5A)NoneX2N A 590 (-4.8A)X2N A 590 (-4.2A)HEM A 580 (-4.1A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)X2N A 590 (-4.8A) | 1.32A | 5eshA-5fsaA:57.7 | 5eshA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ESH_A_1YNA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 12 / 12 | ALA A 61LEU A 88TYR A 118PHE A 126ILE A 131TYR A 132PHE A 228GLY A 307THR A 311LEU A 376PHE A 380MET A 508 | X2N A 590 (-3.5A)NoneX2N A 590 ( 4.0A)X2N A 590 (-4.8A)X2N A 590 (-4.2A)HEM A 580 (-4.1A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 ( 4.8A)X2N A 590 (-4.8A) | 0.75A | 5eshA-5fsaA:57.7 | 5eshA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ESK_A_1YNA701_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 11 / 12 | GLY A 65TYR A 118LEU A 121PHE A 126ILE A 131TYR A 132PHE A 228GLY A 307THR A 311PHE A 380MET A 508 | X2N A 590 ( 4.0A)X2N A 590 ( 4.0A)X2N A 590 (-4.6A)X2N A 590 (-4.8A)X2N A 590 (-4.2A)HEM A 580 (-4.1A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 ( 4.8A)X2N A 590 (-4.8A) | 0.43A | 5eskA-5fsaA:56.0 | 5eskA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ESK_A_1YNA701_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 12 | LEU A 121TYR A 118PHE A 228GLY A 307THR A 311 | X2N A 590 (-4.6A)X2N A 590 ( 4.0A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A) | 1.18A | 5eskA-5fsaA:56.0 | 5eskA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ESK_A_1YNA701_2 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 4 | ALA A 61PRO A 230LEU A 376HIS A 377 | X2N A 590 (-3.5A)X2N A 590 (-4.2A)X2N A 590 (-4.3A)X2N A 590 (-4.3A) | 0.44A | 5eskA-5fsaA:56.0 | 5eskA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ESL_A_1YNA701_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 11 / 12 | GLY A 65TYR A 118PHE A 126ILE A 131TYR A 132PHE A 228GLY A 307THR A 311HIS A 377PHE A 380MET A 508 | X2N A 590 ( 4.0A)X2N A 590 ( 4.0A)X2N A 590 (-4.8A)X2N A 590 (-4.2A)HEM A 580 (-4.1A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 ( 4.8A)X2N A 590 (-4.8A) | 0.49A | 5eslA-5fsaA:57.3 | 5eslA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ESL_A_1YNA701_2 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 5 | ALA A 61TYR A 64PRO A 230GLY A 303LEU A 376 | X2N A 590 (-3.5A)NoneX2N A 590 (-4.2A)X2N A 590 ( 4.8A)X2N A 590 (-4.3A) | 0.52A | 5eslA-5fsaA:57.3 | 5eslA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ESM_A_TPFA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 7 / 7 | TYR A 118PHE A 126ILE A 131PHE A 228GLY A 307THR A 311LEU A 376 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)X2N A 590 (-4.2A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 (-4.3A) | 0.63A | 5esmA-5fsaA:55.8 | 5esmA-5fsaA:59.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HS1_A_VORA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 6 / 8 | PHE A 126ILE A 131PHE A 228GLY A 307THR A 311LEU A 376 | X2N A 590 (-4.8A)X2N A 590 (-4.2A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 (-4.3A) | 0.63A | 5hs1A-5fsaA:55.8 | 5hs1A-5fsaA:59.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HS1_A_VORA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 6 / 8 | TYR A 118PHE A 126ILE A 131PHE A 228GLY A 307THR A 311 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)X2N A 590 (-4.2A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A) | 0.39A | 5hs1A-5fsaA:55.8 | 5hs1A-5fsaA:59.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JLC_A_1YNA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 6 / 12 | ALA A 61PHE A 228GLY A 308THR A 311HIS A 377MET A 508 | X2N A 590 (-3.5A)X2N A 590 (-4.9A)HEM A 580 (-3.6A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 (-4.8A) | 1.00A | 5jlcA-5fsaA:54.7 | 5jlcA-5fsaA:62.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JLC_A_1YNA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 11 / 12 | ALA A 61TYR A 118PHE A 126ILE A 131TYR A 132PHE A 228GLY A 307THR A 311HIS A 377PHE A 380MET A 508 | X2N A 590 (-3.5A)X2N A 590 ( 4.0A)X2N A 590 (-4.8A)X2N A 590 (-4.2A)HEM A 580 (-4.1A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 ( 4.8A)X2N A 590 (-4.8A) | 0.53A | 5jlcA-5fsaA:54.7 | 5jlcA-5fsaA:62.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JLC_A_1YNA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 12 | TYR A 132PHE A 126PHE A 228GLY A 307THR A 311 | HEM A 580 (-4.1A)X2N A 590 (-4.8A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A) | 1.18A | 5jlcA-5fsaA:54.7 | 5jlcA-5fsaA:62.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JLC_A_1YNA602_2 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 5 | TYR A 64GLY A 65GLY A 303LEU A 376 | NoneX2N A 590 ( 4.0A)X2N A 590 ( 4.8A)X2N A 590 (-4.3A) | 0.47A | 5jlcA-5fsaA:54.7 | 5jlcA-5fsaA:62.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V5Z_A_1YNA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 12 / 12 | TYR A 118PHE A 126ILE A 131TYR A 132PHE A 228PHE A 233GLY A 307THR A 311LEU A 376HIS A 377PHE A 380MET A 508 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)X2N A 590 (-4.2A)HEM A 580 (-4.1A)X2N A 590 (-4.9A)X2N A 590 (-4.3A)X2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 (-4.3A)X2N A 590 ( 4.8A)X2N A 590 (-4.8A) | 0.56A | 5v5zA-5fsaA:54.9 | 5v5zA-5fsaA:90.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V5Z_A_1YNA602_2 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 3 / 3 | GLY A 65THR A 122PRO A 230 | X2N A 590 ( 4.0A)NoneX2N A 590 (-4.2A) | 0.48A | 5v5zA-5fsaA:54.9 | 5v5zA-5fsaA:90.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X24_A_LSNA502_1 (CYTOCHROME P450 2C9) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 12 | ASN A 232LEU A 121VAL A 125ASP A 225LEU A 511 | NoneX2N A 590 (-4.6A)NoneNoneNone | 1.24A | 5x24A-5fsaA:30.4 | 5x24A-5fsaA:25.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6AY4_A_TPFA506_1 (CYP51, STEROL14ALPHA-DEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 10 | TYR A 118PHE A 126PHE A 228THR A 311LEU A 376 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)X2N A 590 (-4.9A)HEM A 580 (-3.6A)X2N A 590 (-4.3A) | 1.40A | 6ay4A-5fsaA:40.6 | 6ay4A-5fsaA:36.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6AY4_A_TPFA506_1 (CYP51, STEROL14ALPHA-DEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 10 | TYR A 118PHE A 126THR A 311LEU A 376CYH A 470 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)HEM A 580 (-2.2A) | 0.86A | 6ay4A-5fsaA:40.6 | 6ay4A-5fsaA:36.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6AY4_A_TPFA506_1 (CYP51, STEROL14ALPHA-DEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 10 | TYR A 118TYR A 132PHE A 228THR A 311LEU A 376 | X2N A 590 ( 4.0A)HEM A 580 (-4.1A)X2N A 590 (-4.9A)HEM A 580 (-3.6A)X2N A 590 (-4.3A) | 1.23A | 6ay4A-5fsaA:40.6 | 6ay4A-5fsaA:36.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6AY4_A_TPFA506_1 (CYP51, STEROL14ALPHA-DEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 10 | TYR A 118TYR A 132THR A 311LEU A 376CYH A 470 | X2N A 590 ( 4.0A)HEM A 580 (-4.1A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)HEM A 580 (-2.2A) | 0.66A | 6ay4A-5fsaA:40.6 | 6ay4A-5fsaA:36.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6AY6_A_VORA501_1 (CYP51, STEROL14ALPHA-DEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 6 / 9 | TYR A 118PHE A 126TYR A 132THR A 311LEU A 376CYH A 470 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)HEM A 580 (-4.1A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)HEM A 580 (-2.2A) | 0.73A | 6ay6A-5fsaA:43.5 | 6ay6A-5fsaA:36.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6AYB_A_KKKA508_1 (CYP51, STEROL14ALPHA-DEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 12 | TYR A 118PHE A 126TYR A 132THR A 311LEU A 376 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)HEM A 580 (-4.1A)HEM A 580 (-3.6A)X2N A 590 (-4.3A) | 0.84A | 6aybA-5fsaA:43.4 | 6aybA-5fsaA:36.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AYC_A_1YNA502_1 (PROTEIN CYP51) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 12 | ALA A 61TYR A 118PHE A 126TYR A 132LEU A 376 | X2N A 590 (-3.5A)X2N A 590 ( 4.0A)X2N A 590 (-4.8A)HEM A 580 (-4.1A)X2N A 590 (-4.3A) | 0.92A | 6aycA-5fsaA:43.8 | 6aycA-5fsaA:9.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AYC_A_1YNA502_1 (PROTEIN CYP51) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 5 / 12 | TYR A 118PHE A 126TYR A 132THR A 311LEU A 376 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)HEM A 580 (-4.1A)HEM A 580 (-3.6A)X2N A 590 (-4.3A) | 0.78A | 6aycA-5fsaA:43.8 | 6aycA-5fsaA:9.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6E8Q_A_X2NA602_0 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 11 / 12 | GLY A 65TYR A 118PHE A 126ILE A 131PHE A 228GLY A 307THR A 311LEU A 376HIS A 377PHE A 380MET A 508 | X2N A 590 ( 4.0A)X2N A 590 ( 4.0A)X2N A 590 (-4.8A)X2N A 590 (-4.2A)X2N A 590 (-4.9A)X2N A 590 (-3.5A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)X2N A 590 (-4.3A)X2N A 590 ( 4.8A)X2N A 590 (-4.8A) | 0.52A | 6e8qA-5fsaA:57.2 | 6e8qA-5fsaA:11.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6E8Q_A_X2NA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 4 | TYR A 64LEU A 121TYR A 132PRO A 230 | NoneX2N A 590 (-4.6A)HEM A 580 (-4.1A)X2N A 590 (-4.2A) | 0.37A | 6e8qA-5fsaA:57.2 | 6e8qA-5fsaA:11.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EQP_A_BUWA601_1 (CHOLINESTERASE) |
5fsa | CYP51 VARIANT1 (Candidaalbicans) | 4 / 8 | GLY A 65GLN A 66PHE A 72TYR A 69 | X2N A 590 ( 4.0A)NoneNoneNone | 1.10A | 6eqpA-5fsaA:undetectable | 6eqpA-5fsaA:8.64 |